Asia Pacific Hemostats Market, By Type (Thrombin-Based, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, And Collagen Based Hemostats), - Forecast To 2021
- Report Code: HE 1002
- Publish Date: Upcoming
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding. The usage of hemostats must be quick, localized, and carefully regulated. Although, the usage of hemostats is not required until and unless the bleeding is heavy or the patient is suffering from congenital diseases or trauma defects.
The purpose of this report is to cover the description, definition and forecast of the Asia-pacific Hemostats market. It involves deep dive analysis of market segmentation, which comprises of products type. The Asia-pacific Hemostats market is expected to reach USD 455.9 million by 2021 from USD 290.3 million in 2015, at a CAGR of 7.8% from 2016 to 2021. In 2015, Japan dominated the Hemostats market registering around 32.6% market share, and the region’s market is expected to grow at a CAGR of 7.8% during the forecast period. Factors such as increasing surgery procedures, increasing number of insurance providers are propelling the growth of this market.
By type, the Asia-pacific Hemostats market is divided into thrombin based hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, combination hemostats, and collagen based hemostats. The thrombin based hemostats accounted for the largest share of 29.4% of the Asia-pacific Hemostats market in 2015.
In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports, and interviews with industry experts and key opinion leaders, such as CEOs, directors, and marketing executives.
The major players in this market include Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.). These companies have adopted various strategies, such as mergers & acquisitions and partnerships, among others, to achieve growth in the Asia-pacific Hemostats market.
Scope of the Report:
This report categorizes the Asia-Pacific market for Hemostats on the basis of type, application, end-user, and region.
Market Segmentation, by Type:
Based on type, the Asia-pacific Hemostats market is segmented into Thrombin Based Hemostats, Combination Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Gelatin Based Hemostats, and Collagen Based Hemostats
Market Segmentation, by Geography:
The regional analysis covers Japan, China, India, Republic of Korea, Australia and New Zealand.
Target Audience:
- Biosurgerical Product Manufacturers
- Associations and International Bodies
- Medical Device Companies
- Research and Consulting Firms
- Vendors and Service Providers
- Regulatory Authorities (such as FDA and insurance providers)
Customization Options:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company mapped at the country and subsegment level
- End-user adoption rate analysis of products (segment and country-wise)
- Comprehensive coverage of product approvals, volume data, pipeline products, and product recalls
- Brand/product perception matrix
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Wound Closure Market The North American Wound Closure Market was valued at $1.2 billion in 2013 and is expected to reach $1.4 billion by 2018, at a CAGR of 2.0%. The report “North American Wound closure Market forecast, 2012-2018” analyzes the market of Wound Closure by 3 segments such as Sutures, Staples and Staplers, Tissue adhesives, Sealants and glues. The main companies operating in Wound closure market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare. |
Upcoming |
|
|
European Wound Closure Market The European Wound Closure Market was valued at $431 million in 2013 and is expected to reach $473 million by 2018, at a CAGR of 2.1%. The report “European Wound closure Market forecast, 2012-2018” analyzes the market of Wound Closure by 3 segments such as Sutures, Staples and Staplers, Tissue adhesives, Sealants and glues. The main companies operating in this market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare. |
Upcoming |
|
|
Asian Wound Closure Market The Asian Wound Closure Market was valued at $262 million in 2013 and is expected to reach $294 million by 2018, at a CAGR of 2.6%. The report “Asian Wound closure Market forecast, 2012-2018” analyzes the market of Wound Closure by 3 segments such as Sutures, Staples and Staplers, Tissue adhesives, Sealants and glues. The main companies operating in this market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare. |
Upcoming |
